183205-18-7Relevant academic research and scientific papers
Cancerous metastasis inhibitors containing uracil derivatives
-
, (2008/06/13)
This invention provides a drug which has inhibitory activities against thymidine phosphorylase and inhibits metastasis of a cancer. Specifically, this invention relates to a cancerous metastasis inhibitor comprising, as an active ingredient, a uracil derivative represented by the following formula (1): wherein R1represents a chlorine, bromine or iodine atom or a cyano or lower alkyl group and R2represents a substituted or unsubstituted 4-8 membered hetero-cyclic group having nitrogen atoms or a substituted or unsubstituted amidinothio, guanidino, (lower alkyl)amidino, amino or like group, or a salt thereof.
Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same
-
, (2008/06/13)
The invention relates to novel uracil derivatives having excellent inhibiting effects of human derived thymidine phosphorylase and anti-tumor activity. The pharmaceutical compositions, anti-tumor potentiators, antitumor agents containing such novel compounds, and a process for their preparation and use is described. The novel compounds satisfy the general formula (1): STR1
